Harry Douglas Bentley, John Sandro Burigana and Ned Gino Bragagnolo Partnership, The – Trademark Portfolio

Entity Type: 02

Harry Douglas Bentley, John Sandro Burigana and Ned Gino Bragagnolo Partnership, The holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The owner is based in Downsview, Ontario.

Downsview, Ontario M3L 1A2 , CA

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

MIGRACET
MIGRACET
Abandoned 1993
TANACET
TANACET
Abandoned 1992

Trademark Classifications

Harry Douglas Bentley, John Sandro Burigana and Ned Gino Bragagnolo Partnership, The's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Harry Douglas Bentley, John Sandro Burigana and Ned Gino Bragagnolo Partnership, The have?

Harry Douglas Bentley, John Sandro Burigana and Ned Gino Bragagnolo Partnership, The has 2 U.S. trademarks filed with the USPTO.

What trademark classes does Harry Douglas Bentley, John Sandro Burigana and Ned Gino Bragagnolo Partnership, The file in?

Harry Douglas Bentley, John Sandro Burigana and Ned Gino Bragagnolo Partnership, The files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What is Harry Douglas Bentley, John Sandro Burigana and Ned Gino Bragagnolo Partnership, The's trademark registration success rate?

Harry Douglas Bentley, John Sandro Burigana and Ned Gino Bragagnolo Partnership, The has a 0% trademark registration rate, with 0 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.